Patent details

EP1809293 Title: AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS

Basic Information

Publication number:
EP1809293
PCT Application Number:
PCT/EP/2005/005028
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057478430
PCT Publication Number:
WO/2005/110421
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS
French Title of Invention:
FORMULATION D'AEROSOL POUR L'INHALATION DE BETA-AGONISTES
German Title of Invention:
AEROSOLFORMULIERUNG FÜR DIE INHALATION VON BETAAGONISTEN
SPC Number:

Dates

Filing date:
10/05/2005
Grant date:
16/03/2016
EP Publication Date:
16/03/2016
PCT Publication Date:
24/11/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/07/2007
EP B1 Publication Date:
16/03/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/05/2016
Expiration date:
10/05/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/05/2005
 
 

Name:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Address:
Binger Str. 173, 55216 Ingelheim, Germany (DE)

Name:
Boehringer Ingelheim Pharma GmbH & Co. KG
Address:
Binger Strasse 173, 55216 Ingelheim, Germany (DE)

Inventor

Name:
AVEN Michael
Address:
Germany (DE)

Priority

Priority Number:
102004024452
Priority Date:
14/05/2004
Priority Country:
Germany (DE)

Classification

Main IPC Class:
A61K 31/536;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages